IL17A and arthritic joint disease: Interestingly, neutralizing antibody to IL-17 completely abrogated disease in the anti-IFN-γ alone group, whereas anti-IL-17 had only a partial effect on arthritis in the mice that received anti-IFN-γ + anti-IL-4 (Figure 6a).